In DGC, high expression of FGFR1, FGFR2, or FGFR4 was significantly associated with the depth of invasion, lymph-node metastasis, pathological stage, and distant metastasis or recurrent disease. This evidence concerns the gene FGFR2 and metastatic malignant neoplasm in the lymph nodes.